Add to Google Homepage RSS Subscribe to RSS feed

 

 

Hemophilia News provided by Google

National Hemophilia Foundation Applauds First von Willebrand ... - PR Newswire (press release)

National Hemophilia Foundation Applauds First von Willebrand ...
PR Newswire (press release), NY - May 6, 2008
NEW YORK, May 6 /PRNewswire/ -- The National Hemophilia Foundation (NHF) welcomes and applauds the issuance of the first clinical guidelines in the United ...

Catalyst Biosciences Selects Drug Development Candidate in Factor ... - Earthtimes (press release)

Catalyst Biosciences Selects Drug Development Candidate in Factor ...
Earthtimes (press release), UK - May 6, 2008
In established hemophilia models of acute bleeding, CB 813 has demonstrated a significant improvement in potency compared with the marketed recombinant ...

'Impossible is nothing' for East High's valedictorian - Kansas.com

'Impossible is nothing' for East High's valedictorian
Kansas.com, KS - 22 hours ago
"One of my wishes is to figure out the cure for hemophilia, which is a blood disorder." In Vietnam, one of Trang's best friends had hemophilia. ...

FDA Approves New Formulation of Coagulation Therapy - FDA.gov

FDA Approves New Formulation of Coagulation Therapy
FDA.gov - May 9, 2008
These uses include the treatment of bleeding and the prevention of surgical bleeding in patients with hemophilia A or B, who have antibodies that neutralize ...

Is NASA Vampire With Bad Hemophilia? - Free Market News Network

Is NASA Vampire With Bad Hemophilia?
Free Market News Network, FL - May 1, 2008
... spectacles that hypnotize taxpayers while bleeding them dry. Or is it just a vampire with a bad case of hemophilia? Take your pick. -Strike the Root.
NASA business forum May 16 Akron Beacon Journal
all 3 news articles

Hemophilia Foundation Board of Directors Elects New Officers - Earthtimes (press release)

Hemophilia Foundation Board of Directors Elects New Officers
Earthtimes (press release), UK - Apr 29, 2008
The Hemophilia Foundation of Michigan is located at 1921 W. Michigan Avenue, Ypsilanti. For information, please call 734-544-0015 or 800-482-3041.

Maxygen reports $13.7 million Q1 loss - Bizjournals.com

Maxygen reports $13.7 million Q1 loss
Bizjournals.com, NC - May 6, 2008
Maxygen (NASDAQ: MAXY) seeks treatments for neutropenia, a white blood cell deficiency, as well as for hemophilia and rheumatoid arthritis. ...
Maxygen Reports First Quarter 2008 Financial Results Business Wire (press release)
Maxygen posts wider 1Q loss Forbes
all 9 news articles

Hemophilia Foundation of Michigan Presents Awards at Its Annual ... - Market Wire (press release)

Hemophilia Foundation of Michigan Presents Awards at Its Annual ...
Market Wire (press release) - Apr 22, 2008
YPSILANTI, MI--(Marketwire - April 22, 2008) - Nearly 500 people gathered at the Bavarian Inn Lodge in Frankenmuth to attend SpringFest®, the Hemophilia ...

Innominds Software - Blood Donation Camp - On the Eve of World ... - India PRwire (Press Release)

Innominds Software - Blood Donation Camp - On the Eve of World ...
India PRwire (Press Release), India - Apr 23, 2008
Haemophilia (or hemophilia) is a group of hereditary genetic disorders that impair the body's ability to control blood clotting or coagulation. ...

National Hemophilia Foundation Asks America to Make a Difference ... - Earthtimes

National Hemophilia Foundation Asks America to Make a Difference ...
Earthtimes, UK - Apr 17, 2008
NEW YORK, April 17 -- The National Hemophilia Foundation (NHF) today announced its first-ever national fundraising and awareness campaign -- the Hemophilia ...
Global Bleeding Disorders Community Campaigns To Diagnose At-Risk ... Medical News Today (press release)
all 5 news articles

searching on Hemophilia - Google News



 

 

 

 

 

Home | About Us | Contact Us | Terms of Use | Privacy & Security | Medical Board | Site Map | Login
Last modified: April 04, 2008  © morefocus group, inc.

This site is designed to provide information, not medical advice. Please consult your physician if you have any questions or concerns.